npj Vaccines (Apr 2024)

Realising the potential of correlates of protection for vaccine development, licensure and use: short summary

  • Deborah F. King,
  • Helen Groves,
  • Charlie Weller,
  • Ian Jones,
  • Jakob P. Cramer,
  • Peter B. Gilbert,
  • David Goldblatt,
  • Marion F. Gruber,
  • Beate Kampmann,
  • Diadié Maïga,
  • Marcela F. Pasetti,
  • Stanley A. Plotkin,
  • Alexander Precioso,
  • Liya Wassie,
  • Frederick Wittke,
  • David C. Kaslow

DOI
https://doi.org/10.1038/s41541-024-00872-6
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 9

Abstract

Read online

On 27–29th of September 2022, Wellcome convened an international multi-stakeholder workshop to discuss the use of Correlates of Protection (CoP) to accelerate vaccine development, the hybrid format meeting was attended by 80 delegates including developers, manufacturers, regulators, public health officials and policy-makers from 17 countries, including 7 LMIC’s.